Literature DB >> 12199981

[Treatment of diabetes mellitus: general goals, and clinical practice management].

Rafael Simó1, Cristina Hernández.   

Abstract

Diabetes mellitus is associated with a marked increased of cardiovascular events. The treatment strategy of diabetes has to be based on the knowledge of its pathophysiology. Thus, insulin is essential for treatment of type 1 diabetic patients because there is a defect in insulin secretion. However, treatment of type 2 diabetic patients is more complex because a defect in both insulin secretion and insulin action exists. Therefore, the treatment selection will depend on the stage of the disease and the individual characteristics of the patient. This article examines the general goals of the treatment and reviews the management of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12199981     DOI: 10.1016/s0300-8932(02)76714-6

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  11 in total

1.  Prioritizing the glucose-lowering medicines for type 2 diabetes by an extended fuzzy decision-making approach with target-based attributes.

Authors:  Maryam Eghbali-Zarch; Reza Tavakkoli-Moghaddam; Fatemeh Esfahanian; Sara Masoud
Journal:  Med Biol Eng Comput       Date:  2022-07-01       Impact factor: 3.079

2.  Effect of supplementation with vitamins D3 and K2 on undercarboxylated osteocalcin and insulin serum levels in patients with type 2 diabetes mellitus: a randomized, double-blind, clinical trial.

Authors:  J I Aguayo-Ruiz; T A García-Cobián; S Pascoe-González; S Sánchez-Enríquez; I M Llamas-Covarrubias; T García-Iglesias; A López-Quintero; M A Llamas-Covarrubias; J Trujillo-Quiroz; E A Rivera-Leon
Journal:  Diabetol Metab Syndr       Date:  2020-08-18       Impact factor: 3.320

3.  Healthcare Providers' Perception of Healthcare System Factors Associated with Poor Glycemic Control among Type 2 Diabetes Patients in Fiji.

Authors:  Pablo Romakin; Mohammadnezhad Masoud
Journal:  Rev Diabet Stud       Date:  2019-08-04

Review 4.  Sodium-glucose Cotransporter-2 Inhibitors: Moving Beyond the Glycemic Treatment Goal.

Authors:  Vishal Gupta; William Canovatchel; B N Lokesh; Ravi Santani; Nishant Garodia
Journal:  Indian J Endocrinol Metab       Date:  2017 Nov-Dec

5.  Immediate effect of bitter gourd, ash gourd, Knol-khol juices on blood sugar levels of patients with type 2 diabetes mellitus: A pilot study.

Authors:  G Selvakumar; G Shathirapathiy; R Jainraj; P Yuvaraj Paul
Journal:  J Tradit Complement Med       Date:  2017-02-15

6.  Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.

Authors:  Emanuel L Peter; Serawit Deyno; Andrew Mtewa; Félicien Mushagalusa Kasali; Prakash B Nagendrappa; Duncan Sesaazi; Casim Umba Tolo; Patrick Engeu Ogwang
Journal:  Syst Rev       Date:  2018-11-15

7.  Prevalent, uncontrolled, and undiagnosed diabetes mellitus among urban adults in Dire Dawa, Eastern Ethiopia: A population-based cross-sectional study.

Authors:  Behailu Hawulte Ayele; Hirbo Shore Roba; Addisu Shunu Beyene; Melkamu Merid Mengesha
Journal:  SAGE Open Med       Date:  2020-11-20

8.  Insulin promotes glucose consumption via regulation of miR-99a/mTOR/PKM2 pathway.

Authors:  Wei Li; Jing Wang; Qiu-Dan Chen; Xu Qian; Qi Li; Yu Yin; Zhu-Mei Shi; Lin Wang; Jie Lin; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

9.  Formulation and Evaluation of Multilayered Tablets of Pioglitazone Hydrochloride and Metformin Hydrochloride.

Authors:  Y Ankamma Chowdary; Ramakrishna Raparla; Muramshetty Madhuri
Journal:  J Pharm (Cairo)       Date:  2014-05-12

10.  Prevalence, sociodemographic distribution, treatment and control of diabetes mellitus in Panama.

Authors:  Anselmo J Mc Donald P; Jose A Montenegro G; Clara E Cruz G; Aida L Moreno de Rivera; Alberto Cumbrera O
Journal:  Diabetol Metab Syndr       Date:  2013-11-13       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.